CompletedNCT03349606
Brain Dopamine in People With Cocaine Use
Medication studyAges 18–40United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 40 years.
- Listed locations
- PittsburghSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: June 2, 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- University of Pittsburgh
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, RADIATION
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 40 Years
- Official registry ID
- NCT03349606
- Official title
Show the full official title
Imaging of Cortical Dopamine Transmission in Cocaine Dependence
Get this study by email
Recruitment & locations
CompletedPittsburgh
Questions about this study
Who is behind this study?
The study sponsor is University of Pittsburgh, a university.
Did this study involve medication?
Yes. The study involved medication, including d-amphetamine.
Who was this study for?
Listed age limits: 18 years to 40 years.
